LORETTA GONZALES: Open Payments
NPI 1356005680 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 127 payments from 14 companies in 2025. Trend: 2023 $985 · 2024 $1,991 · 2025 $2,393
Food & beverage: $2,266Education: $126
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $531 |
| Janssen Biotech, Inc. | 17 | $429 |
| Incyte Corporation | 39 | $414 |
| ABBVIE INC. | 22 | $273 |
| GENZYME CORPORATION | 11 | $224 |
| Amgen Inc. | 8 | $146 |
| Lilly USA, LLC | 5 | $97 |
| LEO Pharma Inc. | 2 | $81 |
| UCB, Inc. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
Products named: TREMFYA, OPZELURA, SKYRIZI, DUPIXENT, Rhapsido, OTEZLA, ANZUPGO, TALTZ.
Industry payments across NM — which companies pay providers there.
